BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 7747422)

  • 1. The C/EBP site in the feline immunodeficiency virus (FIV) long terminal repeat (LTR) is necessary for its efficient replication and is also involved in the inhibition of FIV LTR-directed gene expression by pseudorabies virus ICP4.
    Kawaguchi Y; Tomonaga K; Maeda K; Ono M; Miyazawa T; Kohmoto M; Tohya Y; Mikami T
    Virology; 1995 Apr; 208(2):492-9. PubMed ID: 7747422
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The feline herpesvirus type 1 ICP4 down-regulates feline immunodeficiency virus long terminal repeat (LTR)-directed gene expression via the C/EBP site in the LTR.
    Kawaguchi Y; Maeda K; Pecoraro MR; Inoshima Y; Jang HK; Kohmoto M; Iwatsuki K; Ikeda Y; Shimojima M; Tohya Y
    J Vet Med Sci; 1995 Dec; 57(6):1129-31. PubMed ID: 8720064
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of feline immunodeficiency virus gene expression and replication by alphaherpesvirus ICP4 homologues.
    Kawaguchi Y; Maeda K; Miyazawa T; Ono M; Tsubota K; Tomonaga K; Mikami T
    J Gen Virol; 1994 Oct; 75 ( Pt 10)():2783-7. PubMed ID: 7931167
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nucleotide sequence and characterization of the feline herpesvirus type 1 immediate early gene.
    Kawaguchi Y; Maeda K; Miyazawa T; Ono M; Kai C; Mikami T
    Virology; 1994 Oct; 204(1):430-5. PubMed ID: 8091674
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cis- and trans-regulation of feline immunodeficiency virus: identification of functional binding sites in the long terminal repeat.
    Thompson FJ; Elder J; Neil JC
    J Gen Virol; 1994 Mar; 75 ( Pt 3)():545-54. PubMed ID: 8126451
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The AP-1 binding site in the feline immunodeficiency virus long terminal repeat is not required for virus replication in feline T lymphocytes.
    Miyazawa T; Kohmoto M; Kawaguchi Y; Tomonaga K; Toyosaki T; Ikuta K; Adachi A; Mikami T
    J Gen Virol; 1993 Aug; 74 ( Pt 8)():1573-80. PubMed ID: 8393913
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differences in feline immunodeficiency virus host cell range correlate with envelope fusogenic properties.
    Pancino G; Castelot S; Sonigo P
    Virology; 1995 Feb; 206(2):796-806. PubMed ID: 7856093
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of ORF2 on host cell tropism of feline immunodeficiency virus.
    Waters AK; De Parseval AP; Lerner DL; Neil JC; Thompson FJ; Elder JH
    Virology; 1996 Jan; 215(1):10-6. PubMed ID: 8553580
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of gene expression directed by the long terminal repeat of the feline immunodeficiency virus.
    Sparger EE; Shacklett BL; Renshaw-Gegg L; Barry PA; Pedersen NC; Elder JH; Luciw PA
    Virology; 1992 Mar; 187(1):165-77. PubMed ID: 1310554
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of human cytomegalovirus target sequences in the human immunodeficiency virus long terminal repeat. Potential role of IE2-86 binding to sequences between -120 and -20 in promoter transactivation.
    Yurochko AD; Huong SM; Huang ES
    J Hum Virol; 1999; 2(2):81-90. PubMed ID: 10225210
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of sequences in the long terminal repeat of the lymphoproliferative disease virus required for efficient transcription.
    Sarid R; Gazit A; Tronick SR; Yaniv A
    Virology; 1995 Apr; 208(2):789-94. PubMed ID: 7747452
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The gene expression of human foamy virus does not require a post-transcriptional transactivator.
    Lee AH; Lee HY; Sung YC
    Virology; 1994 Oct; 204(1):409-13. PubMed ID: 7522374
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Molecular pathogenesis in tuberculosis complicated with AIDS].
    Nakata K; Hoshino Y; Honda Y; Tanaka N; Hebisawa A; Weiden M
    Kekkaku; 2004 Nov; 79(11):659-67. PubMed ID: 15729891
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of the HIV-1 LTR NF-kappaB-proximal Sp site III: evidence for cell type-specific gene regulation and viral replication.
    McAllister JJ; Phillips D; Millhouse S; Conner J; Hogan T; Ross HL; Wigdahl B
    Virology; 2000 Sep; 274(2):262-77. PubMed ID: 10964770
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The proximal promoter of the human cathepsin G gene conferring myeloid-specific expression includes C/EBP, c-myb and PU.1 binding sites.
    Lennartsson A; Garwicz D; Lindmark A; Gullberg U
    Gene; 2005 Aug; 356():193-202. PubMed ID: 16019164
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhancement of the basal-level activity of HIV-1 long terminal repeat by HIV-1 nucleocapsid protein.
    Zhang JL; Sharma PL; Crumpacker CS
    Virology; 2000 Mar; 268(2):251-63. PubMed ID: 10704334
    [TBL] [Abstract][Full Text] [Related]  

  • 17. cis-acting regulatory elements in the bovine immunodeficiency virus long terminal repeat.
    Fong SE; Pallansch LA; Mikovits JA; Lackman-Smith CS; Ruscetti FW; Gonda MA
    Virology; 1995 Jun; 209(2):604-14. PubMed ID: 7778292
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of insertion of multiple AP-1 binding sites into the U3 region of the long terminal repeat of feline immunodeficiency virus.
    Miyazawa T; Tomonaga K; Kawaguchi Y; Kohmoto M; Inoshima Y; Maeda K; Mikami T; Maedadel K [corrected to Maeda K]
    Arch Virol; 1994; 139(1-2):37-48. PubMed ID: 7529991
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of the vif gene of feline immunodeficiency virus.
    Shacklett BL; Luciw PA
    Virology; 1994 Nov; 204(2):860-7. PubMed ID: 7941360
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of feline immunodeficiency virus Vif is associated with reduced viral mutation rates without restoration of replication of vif mutant viruses.
    Paul TA; Casey JW; Avery RJ; Sutton CA
    Virology; 2007 Apr; 361(1):112-22. PubMed ID: 17169394
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.